Why the study?
Cardiomyopathies are associated with substantial morbidity and mortality in pregnancy.
This review summarizes the etiologies, complications, and management strategies for various forms of cardiomyopathy during pregnancy.
Answers are grounded in this paper and cite their sources.
Synthesizes management strategies for cardiomyopathies in pregnancy; leaves open the need for prospective trials to refine protocols.
The cardiomyopathies are a diverse group of disorders characterized by structural abnormalities of heart muscle, many of which have a genetic component. They are associated with substantial morbidity and mortality in pregnancy. We review the distinct forms of cardiomyopathy (dilated, hypertrophic, and functional) which can be seen during pregnancy, discuss complications associated with each distinct group such as heart failure, arrhythmias, and transmission to offspring, and address management strategies for stable and unstable patients.
No takes yet. Share an insight, caveat, or question.
Briller et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: